(Q61967636)
Statements
A Randomized, Double-blind, Four-period Crossover Study to Investigate the Effect of Intravenous Ondansetron, a 5-HT3 Antagonist, on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects (English)
0 references
16 August 2011
0 references
19 December 2011
0 references
60
0 references
18 year
0 references
45 year
0 references